Dolphin
Senior Member (Voting Rights)
Dr Stanley Du Preez, MD PhDDr Du Preez is a clinician-scientist whose doctoral research was undertaken specifically in ME.
His PhD, completed at the National Centre for Neuroimmunology and Emerging Diseases, Griffith University, characterised transient receptor potential ion channel function in the natural killer cells of patients with ME.
He has authored several peer-reviewed ME publications, including first-authored original research and co-authored systematic reviews.
He also volunteers with ME Group Australia to enhance clinician awareness and care provision.
Clinically, he manages medical conditions within a Queensland Health hospital service, and intends to develop a specialist practice in Clinical Immunology with a focus on ME, motivated by the paucity of Australian clinicians with expertise in this condition.ORCID Profile: https://orcid.org/0009-0001-4305-5250
===
Myalgic Encephalomyelitis | Evidence-Based Management
Dr Du Preez explores evidence-based diagnosis and management of Myalgic Encephalomyelitis (ME), a serious neurological disease, with particular emphasis on Post-Exertional Neuroimmune Exhaustion (PENE) as its defining feature.
He discusses the International Consensus Criteria (ME-ICC), clinical assessment, severity, pacing, management of orthostatic intolerance and other co-occurring conditions, and pharmacological and non-pharmacological approaches.
The presentation also addresses the complex care needs of people with severe and very severe ME, the risks of harmful interventions such as Graded Exercise Therapy (GET), and concerns about outdated Australian clinical recommendations.
The central message: recognise PENE, provide appropriate individualised care, prevent deterioration, and above all, do no harm.
Slide Deck: https://megroupaustralia.org.au/wp-...829-Dr-Stanley-Du-Preez-MD-PhD-Slide-Deck.pdf
